Vimarsana
Biggest News Aggregation in the World

Page 12 - Rob Grenfell News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rob Grenfell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rob Grenfell Today - Breaking & Trending Today

New heat-tolerant COVID-19 vaccine readies for human trials - Vimarsana News

New heat-tolerant COVID-19 vaccine readies for human trials

New heat-tolerant COVID-19 vac... A new vaccine is even stable for up to 90 minutes at boiling temperatures of 100 °C CSIRO 1/1 A new vaccine is even stable for up to 90 minutes at boiling temperatures of 100 °C CSIRO A new heat-tolerant COVID-19 vaccine has delivered strong preclinical results. The vaccine can remain stable for up to 30 days at around 37 °C (98 °F) and researchers are looking to begin human trials later this year. One particular challenge in effectively distributing COVID-19 vaccines across the world is the need for most vaccines to be kept at cold temp...

CSIRO Health Director calls for 'harder' restrictions otherwise COVID 'goes wild' - Vimarsana News

CSIRO Health Director calls for 'harder' restrictions otherwise COVID 'goes wild'

CSIRO Health Director calls for 'harder' restrictions otherwise COVID 'goes wild' One of Australia's top scientific authorities has said that Sydney should install harder COVID lockdown measures or warns "the virus goes wild". CSIRO Health Director Dr Rob Grenfell told Weekend Today that NSW should be looking at Victoria's harder lockdown measures to stop the more extensive spread of human-to-human contact. The warning comes as New South Wales yesterday recorded 97 new local cases and Victoria recorded six new local cases. READ MORE: One of Australia's top scientific authorities has said tha...

IISc-Bengaluru's 'warm' COVID vaccine powerful against all significant variants of concern: Study - Vimarsana News

IISc-Bengaluru's 'warm' COVID vaccine powerful against all significant variants of concern: Study

Date: 16 Jul,2021 A heat-tolerant COVID-19 vaccine formulation developed by the Indian Institute of Science (IISc) Bengaluru has proven effective against all current SARS-CoV-2 variants of concern, according to a study in animals. The research, published in the ACS Infectious Diseases journal on Thursday, showed the vaccine formulations by IISc-incubated biotech start-up Mynvax triggered a strong immune response in mice. The formulation also protected hamsters from the virus and remained stable at 37 degrees Celsius up to a month, and at 100 degrees Celsius for up to 90 minutes, the research...

IISc's 'warm' COVID-19 vaccine effective against all major variants: Study - Vimarsana News

IISc's 'warm' COVID-19 vaccine effective against all major variants: Study

It remained stable at 37 degrees Celsius for a month The formulation also protected hamsters from the deadly virus and remained stable at 37 degrees Celsius for up to a month, and at 100 degrees Celsius for up to 90 minutes, the researchers said. The team, including researchers from Australia's Commonwealth Scientific and Industrial Research Organization (CSIRO), noted that most vaccines require refrigeration to remain effective. Information Almost all other vaccines require refrigeration ...

'Warm' COVID-19 vaccine effective against all key variants: study - Vimarsana News

'Warm' COVID-19 vaccine effective against all key variants: study

Australia's national science agency has found that a "warm" COVID-19 vaccine suitable for remote locations is effective against all key variants of the virus. In a study published on Thursday, researchers from the Commonwealth Scientific and Industrial Research Organization (CSIRO) evaluated the efficacy of heat-tolerant coronavirus vaccine formulations developed by the Indian Institute of Science (IISc) and biotechnology company Mynvax. They found that the formulations triggered a strong immune response against all SARS-CoV-2 variants of concern in mice and hamsters. "Our data shows that all...

Source: ecns.cn